3. Organisation for Economic Co-operation and Development
(OECD)
The Organisation for Economic Co-operation and Development (OECD)
is an inter-governmental organisation in which representatives of 29
industrialised countries in
North America,
Europe
Pacific, as well as the European Commission
meet to co-ordinate and harmonize policies, discuss issues of mutual
concern, and work together to respond to international problems.
4. The work of the OECD related to chemical safety is carried out in the
Environmental Health and Safety Division.
The Environmental Health and Safety Division publishes free-of charge
documents in six different series:
Testing and Assessment
Principles on Good Laboratory Practice and Compliance Monitoring
Pesticides
Risk Management
Chemical Accidents and Harmonization of Regulatory Oversight in
Biotechnology.
5. Good Laboratory Practice (GLP)
“Good Laboratory Practice (GLP) is a quality system concerned with the
organizational process and the conditions under which non-clinical
health and environmental safety studies are planned, performed,
monitored, recorded, archived and reported.”
The Principles of Good Laboratory Practice (GLP) have been developed
to promote the quality and validity of test data used for determining the
safety of chemicals and chemical products.
6. WHY WAS GLP CREATED?
In the early 70’s FDA became aware of cases
of poor laboratory practice all over the
United States.
They discovered a lot fraudulent activities and
a lot of poor lab practices.
Examples of some of these poor lab practices
found were
1. Equipment not been calibrated to standard
form , therefore giving wrong
measurements.
2. Incorrect/inaccurate accounts of the actual
lab study.
3. Inadequate test systems.
8. 8
GLP
GLP TIMELINE
1972
GLP was first introduced in New
Zealand
Early 1970s
Industrial Bio Test Lab case
was most notable
FDA became aware of
cases of poor laboratory
practice all over the US
decided to do an in-depth
Investigation on 40 toxicology labs.
1978
FDA promulgated the
Good Laboratory Practice
(GLP) Regulations under the Special
Programme on the Control of
Chemicals.
9. 9
GLP
National GLP-compliance Monitoring
Authority
was established by the Department of
Science and Technology, Govt of India.
1981
An organization named
OECD produced GLP
principles that are
international standards
International Standard
2002
2011
India became full-member
for Mutual Acceptance of
Data (MAD) in the OECD's
Working Group on GLP
10. Purpose of GLPs:
GLP is to certify that every step of the analysis is valid or
Not.
To promote the development of quality test data.
Comparable quality of test data forms the basis for the
mutual acceptance of data among countries.
The application of these Principles should help to avoid
the creation of technical barriers to trade, and further
improve the protection of human health and the
environment.
GLPs emphasize on data recording, record & specimen
retention.
11. Scope
These Principles of Good Laboratory Practice should be applied to the non-
clinical safety testing of test items contained in
Pharmaceutical products
Pesticide products
Cosmetic products
Veterinary drugs
Food additives and feed additives
Industrial chemicals.
The purpose of testing these test items is to obtain data on their properties
and/or their safety with respect to human health and/or the environment.
13. 13
GLP
GLP Principles
01 02 03 04
08 07 06 05
Test Facility
Organisation and
Personnel
Quality Assurance
Programme
Facilities Apparatus, Material &
Reagents
Reporting of
Study Results
Performance of
the Study
Test and Reference
Items & SOP
Test Systems
09
Storage and
Retention of
Records and
Materials
14. 14
GLP
Test Facility Organisation and Personnel
Test Facility Management’s Responsibilities
Ensure sufficient number of qualified personnel, appropriate facilities, equipment, and
materials
Ensure the maintenance of a record of the qualifications, training, experience.
Proper training of personnel to assigned functions
Job description for each professional and technical individual.
To establish and follow SOP
Quality assurance program with designated personnel
15. 15
GLP
Study Director’s responsibilities
Approval of protocols & the study plan including amendments
Ensure QA personnel and study personnel are updated with study plans & SOP
Ensure the follow up of SOPs periodically and take appropriate corrective action
Archiving Raw data, supporting materials and final report.
The individual responsible for the
overall conduct of the non-clinical
health and environmental safety study
16. Ensure that all raw data generated are fully documented and
recorded;
Ensure that computerised systems used in the study have been
validated;
Sign and date the final report to indicate acceptance of
responsibility for the validity of the data and to indicate the
extent to which the study complies with these Principles of Good
Laboratory Practice;
Ensure that after completion (including termination) of the study,
the study plan, the final report, raw data and supporting material
are archived.
17. 17
GLP
Ensures that the delegated
phase of study is conducted
in accordance with GLP.
Principal Investigator’s Responsibilities
18. Study Personnel’s Responsibilities
All personnel involved in the conduct of the study must be knowledgeable
in those parts of the Principles of Good Laboratory Practice which are
applicable to their involvement in the study.
Study personnel will have access to the study plan and appropriate
Standard Operating Procedures applicable to their involvement in the
study.
Recording of all raw data in compliance with the principles of GLP
Deviations from the instructions to be reported the PI or SD
Takes health precautions and personal safety
19. Quality Assurance Programme
The test facility should have a documented Quality Assurance
Programme to assure that studies performed are in compliance with
these Principles of Good Laboratory Practice.
The Quality Assurance Programme should be carried out by an
individual or by individuals designated by and directly responsible to
management and who are familiar with the test procedures.
This individual(s) should not be involved in the conduct of the study
being assured.
20. 20
GLP
Responsibilities of Quality Assurance Peronnel
Maintains copies of protocols & SOPs
Conduct inspections to determine if all studies are conducted in
accordance with these Principles of Good Laboratory Practice. –
Study-based inspections
Facility-based inspections
Process- based inspections
Determines any deviation from approved protocol and report to SD, PI & management
Prepare a statements to be included in final report containing dates & types of inspection
An individual or a group designated
by management to assure studies are
in compliance with GLP Principles
21. 21
GLP
Facilities
Test System Facilities
Sufficient amount of rooms and areas to assure isolation of test systems
Adequately protected storage area separate from test systems
Areas available for the diagnosis, treatment and control of diseases
Archive facilities
Archive facilities should be provided for the secure storage and retrieval
of study plans, raw data, final reports, samples of test items and
specimens. & prevent untimely deterioration of the specimen.
Waste Disposal
Appropriate collection, storage & disposal facilities
and decontamination procedures
Should not jeopardise the integrity of the study
22. 22
GLP
Apparatus, Materials & Reagents
Apparatus, including validated
computerised systems should be
of appropriate design &
adequate capacity
Chemicals, reagents and
solutions should be labelled
to indicate identity, Conc,
date of expiry & storage
instructions
Apparatus to be periodically
inspected, cleaned, maintained,
and calibrated according to
Standard Operating Procedures.
Should not interfere adversely
with the test systems.
23. 23
GLP
Test Systems
Physical/ Chemical –
Appropriately designed apparatus and of adequate capacity
Integrity of test systems to be ensured
Biological –
Proper storage, housing and handling conditions
Isolation of newly received animals / plants for evaluation and acclimatisation
Information regarding identity at the containers
Records of source, date of arrival and arrival condition
Test systems used in field studies should be located in such a place to avoid interference in
the study.
24. 24
GLP
Receipt, Handling, Sampling and Storage
1. Records including test item and reference item characterisation, date of receipt,
expiry date, quantities received and used in studies should be maintained.
2. Handling, sampling, and storage procedures should be identified in order that the
homogeneity and stability are assured to the degree possible and contamination or
mixup are precluded.
3. Storage container(s) should carry identification information, expiry date, and
specific storage instructions.
Test & Reference Items
25. 25
GLP
Characterisation
1. Each test and reference item should be appropriately identified (e.g., code, Chemical
Abstracts Service Registry Number [CAS number], name, biological parameters).
2.For each study, the identity, including batch number, purity, composition, concentrations,
or other characteristics to appropriately define each batch of the test or reference items should
be known.
3. The stability of test and reference items under storage and test conditions should be known
for all studies.
4. If the test item is administered or applied in a vehicle, the homogeneity, concentration and
stability of the test item in that vehicle should be determined.
26. 26
GLP
Standard Operating Procedure
1. A test facility should have written Standard Operating Procedures approved by test
facility management that are intended to ensure the quality and integrity of the
data generated by that test facility.
2. Each separate test facility unit or area should have immediately available current
Standard Operating Procedures relevant to the activities being performed therein.
3. Deviations from Standard Operating Procedures related to the study should be
documented and should be acknowledged by the Study Director and the Principal
Investigator(s), as applicable.
27. Standard Operating Procedures should be available for, but not be limited to,
the following categories of test facility activities.
1. Test and Reference Items
Receipt, identification, labelling, handling, sampling and storage.
2. Apparatus, Materials and Reagents
Apparatus Use, maintenance, cleaning and calibration.
Computerised Systems Validation, operation, maintenance, security, change
control and back-up.
Materials, Reagents and Solutions Preparation and labelling.
28. 3. Test System
Room preparation and environmental room conditions for the test system.
Procedures for receipt, transfer, proper placement, characterisation,
identification and care of the test system.
Test system preparation, observations and examinations, before, during and
at the conclusion of the study.
Handling of test system individuals found moribund or dead during the
study.
Collection, identification and handling of specimens including necropsy and
histopathology.
Siting and placement of test systems in test plots.
29. 4. Record Keeping, Reporting, Storage, and Retrieval
Coding of studies, data collection, preparation of reports, indexing
systems, handling of data, including the use of computerised systems.
5. Quality Assurance Procedures
Operation of Quality Assurance personnel in planning, scheduling,
performing, documenting and reporting inspections.
30. 30
GLP
Performance ofThe Study
Contents of Study Plan
Identification of the study, the test and reference item
Information - sponsor and the test facility, SD, PI
Dates
Test methods – reference to OECD/other test guidelines
Issues – justification of selection
Records
For each study, a written plan –
• Approved by SD,
• Verified for GLP compliance by QAU
• Approved byTFmanagement, sponsor If required by national regulation in the country
31. Conduct of the Study
Unique identification for each test item and study.
According to the study plan
All data generated during the conduct of the study should be recorded directly,
accurately, and legibly by the individual entering the data.
These entries should be signed or initialled and dated.
32. Reporting of Study Results
A final report should be prepared for each study. In the case of short term
studies, a standardised final report accompanied by a study specific extension
may be prepared.
Reports of Principal Investigators or scientists involved in the study should be
signed and dated by them.
The final report should be signed and dated by the Study Director to indicate
acceptance of responsibility for the validity of the data.
Corrections and additions to a final report should be in the form of
amendments. and should be signed and dated by the Study Director.
Reformatting of the final report to comply with the submission requirements of
a national registration.
33. 33
GLP
Contents of the final report
Information
Test Facility, Sponsor
SD, PI, Study Personnel, Scientists
Identification
Study title
Test & Reference Item
Characterization of purity, stability
Dates
Starting & completion dates
Statement
QAP statement with details of
inspections
Results
A summary
Analysis, Discussions
Description
Materials & methods
Ref. To OECD guidelines
Storage
Location of study plans, samples of
test and reference items, specimens,
raw data and the final report are to be
stored.
34. 34
GLP
Storage & Retention of Records and Materials
The study plan, raw data, samples of test and reference items, specimens and the final report of
each study.
Records of all inspections by QAP
Records of qualifications, training, experience and job descriptions of personnel.
Records and reports of the maintenance and calibration of apparatus.
Historical files of all SOP
Environmental monitoring records.
35. What Good Laboratory Must Contain.?
Area should be free from smoke, smell, dust etc.
Ensure good ventilation, proper illumination and prefer
natural light.
Air conditioned lab with humidity control.
Enough space for measuring and testing instrument.
36. Cont…
Proper arrangement of testing.
Take care of all safety points including proper earthing as well
as fire safety.
Establish proper areas for storage of incoming samples as well
as test–completed samples.
Also provide sample collection place as well as packing and
disposal of tested samples.
37. 37
GLP
NGCMA
National GLP-compliance Monitoring Authority was established by the
Department of Science & Technology
Approval of the Union Cabinet on April 24, 2002
Full-member for Mutual Acceptance of Data (MAD) in the OECD's Working
Group on GLP from March, 2011
38. 38
GLP
Application
• The test facilities/ laboratories
have to apply in the prescribed
application form
Inspection
• A pre-inspection of the laboratory is carried
out by the GLP inspectors, followed by a
final inspection.
Report
Submission
• The report, prepared by the
inspection team, is put to the
Technical Committee for
recommendation to Chairman,
NGCMA
Certification
•GLP-compliance Certification
(valid for a 3 years)
GLP Certification process
40. Do this for GLP
Keep the things at its location after use.
Store heavy things at bottom & if possible on Trollies.
Give name of location to everything.
Follow “Everything has the place & Everything at its place” principle.
Prepare location list & display it.
Put ladders for things stored on top.
Identify everything with its name/ purpose.
Follow “FIFO” to prevent old accumulation for laboratory chemicals.
41. Benefits of good laboratory practices.
It will give better image of company as a Quality producer in
Global market.
Provide tips on analysis of data as well as measure
uncertainty and perfect record keeping.
Provide guideline for doing testing and measurement in
detail.
Provide guidelines and better control for maintenance of
instruments, environment control, preservation of test
records etc
42. 42
GLP
• GLP is an FDA regulation which is accepted and approved as international
standards by OECD
to avoid the fraud activities
of the testing laboratories for
pesticides, pharmaceuticals,
food additives, dyes
to save the human and
environmental health
also erect good
international trade and
establish good relationship
among the countries
• GLP compliance is monitored in India by NGCMA since 2002.
Summary
Editor's Notes
Poorly-trained Study Directors and study personnel
Poorly-designed protocols
Raw data badly collected - not correctly identified, without traceability - not verified or approved by responsible persons
Poor animal husbandry
Equipment not properly calibrated or otherwise qualified
Inadequate archives and retrieval processes
In 1976, the FDA published a draft regulation on GLP and requested comments from
interested parties.
After the consultation period, the final regulation was published in 1978 - This came into force in 1979.
Although this was a US regulation, it had a wide impact worldwide. Non-US companies wishing to register medicines in the USA now
had to perform safety studies in compliance. Many countries introduced their own GLP regulations.
The OECD produced GLP Principles in 1981.
with FDA GLP. data generated in the testing of chemicals in one OECD Member Country, in accordance with OECD Test Guidelines and the Principles of GLP are accepted in all other OECD Member Countries.
An individual who, for a multi-site study, acts on behalf of the Study Director and has defined responsibility.